FILE:UNH/UNH-8K-20120312071211.txt.gz
EVENTS:	Regulation FD Disclosure
TEXT:
ITEM: Regulation FD Disclosure
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[  ]  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) [  ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) [  ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) [  ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Top of the Form
Item 7.01 Regulation FD Disclosure.
Senior members of the UnitedHealth Group Incorporated (the "Company") management team will be making a presentation at the Barclays Capital Global Healthcare Conference in Miami, Florida on Tuesday, March 13, 2012 at 10:15 a.m., Eastern Time. The topic of the presentation will be UnitedHealthcare and its position for growth. The Company will have an audio webcast from, and will post a copy of the presentation on, the Investors page of its website at www.unitedhealthgroup.com. The information in this Item 7.01 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any Company filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.
Top of the Form
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


